52 results match your criteria: "Bharti Hospital and B.R.I.D.E.[Affiliation]"
Diabetes Ther
June 2015
Bharti Hospital and B.R.I.D.E, Karnal, Haryana, 132001, India,
Coformulations are a novel pharmaceutical development in diabetology. They are composed of two medicinal products, both of which maintain their distinct pharmacokinetic and pharmacodynamic properties. Currently available coformulations include combinations of basal and rapid-acting insulin, and basal and glucagon-like peptide 1 receptor agonists (GLP1RA).
View Article and Find Full Text PDFIndian J Endocrinol Metab
March 2015
Department of Endocrinology, Excel Hospitals, Guwahati, Assam, India.
Indian J Endocrinol Metab
January 2015
Diabetes Care and Research Centre, Patna, Bihar, India.
Aim: The aim of the following study is to evaluate the safety and effectiveness of switching from biphasic human insulin (BHI) to biphasic insulin aspart 30 (BIAsp 30) in Indian patients with type 2 diabetes as a sub-analysis of the 24-week, non-interventional A1chieve study.
Materials And Methods: Indian patients switching from BHI to BIAsp 30 based on the physicians' decisions were included. The primary outcome was the incidence of serious adverse drug reactions (SADRs), including major hypoglycemic events; secondary outcomes included changes in hypoglycemia in the 4 weeks preceding baseline and week 24 and changes from baseline to week 24 in glycated hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), postprandial plasma glucose (PPPG), body weight and quality of life (QoL).
Indian J Endocrinol Metab
January 2015
CEO, Chellaram Diabetes Institute, Pune, Maharashtra, India.
Indian J Endocrinol Metab
November 2014
Department of Endocrinology, Osmania medical College, Hyderabad, Telangana, India.
Indian J Endocrinol Metab
November 2014
Indian Journal Endocrinology and Metabolism, Journal of Social Health in Diabetes, Bharti Hospital and B.R.I.D.E., Karnal 132001, Haryana, India.
Diabetes Ther
December 2014
Bharti Hospital and B.R.I.D.E., Karnal, India,
Sodium-glucose co-transporter-2 (SGLT2) inhibitors are a newly developed class of oral anti-diabetic drugs (OADs) with a unique mechanism of action. This review describes the biochemistry and physiology underlying the use of SGLT2 inhibitors, and their clinical pharmacology, including mechanism of action and posology. The pragmatic placement of these molecules in the existing OAD arena is also discussed.
View Article and Find Full Text PDFIndian J Endocrinol Metab
September 2014
Department of Endocrinology, Bharti Hospital and B.R.I.D.E., Karnal, Haryana, India.
J Pharm Bioallied Sci
July 2014
Department of Endocrinology, ECXEL Center, Guwahati, Assam, India.
The prevalence of diabetes mellitus (DM) has increased exponentially throughout the world and there is rapid increase in elderly diabetics. DM is associated with increased mortality and considerable morbidity including stroke, heart disease, and diminished quality of life in the elderly. However, the unique features of geriatric diabetes have not been given due a prominence in medical literature.
View Article and Find Full Text PDFJ Midlife Health
April 2014
Department of Medicine, Government Medical College, Chandigarh, India.
Indian J Endocrinol Metab
May 2014
Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India.
Objectives: DiabCare India 2011 was a cross-sectional study in patients with diabetes mellitus, undertaken to investigate the relationship between diabetes control, management and complications in a subset of urban Indian diabetes patients treated at referral diabetes care centres in India.
Materials And Methods: This was a cross-sectional, multicentre (330 centres) survey in 6168 diabetes patients treated at general hospitals, diabetes clinics and referral clinics across India. Patient data, including medical and clinical examination reports during the past year were collected during their routine visit.
Indian J Endocrinol Metab
March 2014
Department of Endocrinology, Bharti Hospital and B.R.I.D.E., Karnal, Haryana, India.
J Midlife Health
July 2013
Department of Endocrinology, Medanta Hospital, Gurgaon, India.
Background: Cross-cultural differences in attitudes and practices related to diabetes are well-known. Similar differences in symptom reporting of endocrine conditions such as menopause are well documented. Minimal literature is available on the cross-cultural variation in reporting of hypoglycemic symptoms.
View Article and Find Full Text PDFJ Assoc Physicians India
January 2013
Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry.
A wide range of sources have been used to create an equally wide range of types of insulin (rapid acting, fast acting, premixed, intermediate acting and long acting). While some of these insulins are no longer in clinical use, others are being used extensively across the world. Premixed insulin is the most frequently prescribed and used insulin in Asia; basal insulin is more extensively used in USA.
View Article and Find Full Text PDFIndian J Endocrinol Metab
November 2013
Bharti Hospital and B.R.I.D.E., Karnal, Haryana, India.
Indian J Endocrinol Metab
October 2013
Department of Endocrinology, Bharti Hospital and B. R. I. D. E., Karnal, Haryana, India.
Indian J Endocrinol Metab
December 2012
Bharti Hospital and B.R.I.D.E., Karnal, India.
Introduction: The effectiveness and impact of the Indian insulin guideline in clinical practice was evaluated by the Improving Management Practices and Clinical Outcomes in Type 2 Diabetes (IMPACT) Study. The study also evaluated the participating physicians' perceptions on the use of IIG versus RCP for management of diabetes.
Materials And Method: This 26 week multicenter, open label, randomized, prospective study aimed to evaluate effectiveness of Indian insulin guideline (IIG) versus routine clinical practice (RCP) in patients with type 2 diabetes (T2D).
J Midlife Health
July 2012
Department of Endocrinology, Bharti Hospital and B.R.I.D.E, Karnal, Haryana, India.
J Assoc Physicians India
January 2012
Bharti Hospital and B.R.I.D.E, Karnal, India.
Indian J Endocrinol Metab
May 2012
Department of Endocrinology, Bharti Hospital and B.R.I.D.E, Karnal, Haryana, India.
There are established guidelines for the endocrine and overall treatment of transsexual persons. These guidelines provide information about the optimal endocrine management of male-to-female and female-to-male transsexual persons. India has a large community of eunuchs, also known as hijras, who are men with gender identity disorders.
View Article and Find Full Text PDFIndian J Endocrinol Metab
May 2012
Department of Endocrinology, Bharti Hospital and B.R.I.D.E, Karnal, Haryana, India.
Indian J Endocrinol Metab
May 2012
Department of Endocrinology, Bharti Hospital and B.R.I.D.E, Karnal, Haryana, India.
Indian J Endocrinol Metab
March 2012
Department of Endocrinology, Bharti Hospital and B.R.I.D.E, Karnal, Haryana, India.
The pineal gland is a tiny endocrine gland whose physiologic role has been the focus of much research and much more speculation over the past century. This mini-review discusses recent findings which correlate melatonin and renal physiology, and postulates the presence of a "reno-pineal axis." Drawing lessons from comparative endocrinology, while quoting human data, it advocates the need to study the "reno-pineal axis" in greater detail.
View Article and Find Full Text PDFIndian J Endocrinol Metab
March 2012
Department of Endocrinology, Bharti Hospital and B.R.I.D.E, Karnal, Haryana, India.